ALERT Act of 2019

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act; HR 3878, the Block, Report, and Suspend Suspicious Shipments Act of 2019; HR 4812, the Ensuring Compliance Against Drug Diversion Act; HR 4814, the Suspicious Order Identification Act of 2019

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention; Implementation of 21st Century Cures (H.R. 34), advocacy related to healthcare technology and innovation issues; E-Rx (H.R.3528), advocacy related to electronic prescriptions of medications; Implementation of FY'2018 NDAA provision related to e-Commerce portals; education about potential improvements to Prescription Drug Monitoring Programs; H.R. 6 Substance Use- Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act; Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy and other issues related to opioid abuse. H.R. 6637, the Health Equity and Accountability Act (HEAA), H.R. 4621, the Collecting and Analyzing Resources Integral and Necessary for Guidance (CARING) for Social Determinants Act of 2019, S. 2986/H.R. 4004, the Social Determinants Accelerator Act, S.4264 - U.S. MADE Act of 2020, H.R. 6880 - The Buy American Medical Supplies Act, H.R. 6930 - MADE in America Act, H.R. 3 Lower Drug Costs Now Act of 2019, H.R.1845 - ALERT Act of 2019. Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R.748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution

Client expense: $340,000 · Firm income: Not reported

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); the Protecting Jessica Grubbs Legacy Act (S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act; issues related to modernization of HCAHPS; add HR 133, the Consolidated Appropriations Act 2021.

Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention; Implementation of 21st Century Cures (H.R. 34), advocacy related to healthcare technology and innovation issues; E-Rx (H.R.3528), advocacy related to electronic prescriptions of medications; Implementation of FY'2018 NDAA provision related to e-Commerce portals; education about potential improvements to Prescription Drug Monitoring Programs; H.R. 6 Substance Use- Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act; Education about improvements to Prescription Drug Monitoring programs that would promote greater efficiency and utility at the pharmacy and other issues related to opioid abuse. H.R. 6637, the Health Equity and Accountability Act (HEAA), H.R. 4621, the Collecting and Analyzing Resources Integral and Necessary for Guidance (CARING) for Social Determinants Act of 2019, S. 2986/H.R. 4004, the Social Determinants Accelerator Act, S.4264 - U.S. MADE Act of 2020, H.R. 6880 - The Buy American Medical Supplies Act, H.R. 6930 - MADE in America Act, H.R. 3 Lower Drug Costs Now Act of 2019, H.R.1845 - ALERT Act of 2019

Client expense: $230,000 · Firm income: Not reported

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); the Protecting Jessica Grubbs Legacy Act (S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act; issues related to modernization of HCAHPS.

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act; HR 3878, the Block, Report, and Suspend Suspicious Shipments Act of 2019; HR 4812, the Ensuring Compliance Against Drug Diversion Act; HR 4814, the Suspicious Order Identification Act of 2019

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012 and S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response; Issues around CDC and data infrastructure modernization: H.R. 748, the Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. Issues related to telemental and telebehavioral health; issues related to remote patient monitoring; the Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 (H.R. 7190/S. 3951); issues related to ERISA and telehealth; issues related to broadband and infrastructure development; the Protecting Access to Post-Covid-19 Telehealth Act.

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012 and S. 3374); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115); issues related to the COVID-19 pandemic response

Client expense: Not reported · Firm income: $20,000

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334; H.R. 4810, the Opioid Prescription Verification Act of 2019; S. 3070, the Preventing Pill Mills Through Data Sharing Act

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/HR 4932); Issues related to health data privacy; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 2740) - issues related to unique patient identifier and patient matching; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115)

Client expense: Not reported · Firm income: $20,000

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act (HR 6502, 115th); the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic; Prescription Drug Pricing Reduction Act (S. 2543); Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act (H.R. 2115)

Client expense: Not reported · Firm income: $20,000

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act (HR 6502, 115th); The Analyzing and Leveraging Existing Rx Transactions Act (HR 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic.

Client expense: Not reported · Firm income: $20,000

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334

Client expense: $320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act (HR 6502, 115th); the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); The Analyzing and Leveraging Existing Rx Transactions Act (HR 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic.

Client expense: Not reported · Firm income: $20,000

H.R. 127, CARERS Act of 2019; H.R. 171, the Legitimate Use of Medical Marihuana Act; H.R. 1845, ALERT Act of 2019; S. 516, Prescription Drug Monitoring Act of 2019; H.R. 1588, Ending Federal Marijuana Prohibition Act of 2019; Implementation of pharmacy provisions of Public Law No: 115-271; Implementation of Hemp provisions of Public Law No: 115-334

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act; the Analyzing and Leveraging Existing Rx Transactions Act of 2019 (H.R. 1845); issues related to 42 CFR Part 2; issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services. The "Analyzing and Leveraging Existing Rx Transactions Act" HR 1845; Update 42 CFR Part 2 governing substance use disorder treatment records; issues relating to increased access to treatment for opioid misuse and abuse;issues relating to increased use of technology to combat opioid epidemic.

Client expense: Not reported · Firm income: $20,000